StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.25−0.03 (-9.88%)

Close on Nov 18, 2026Market cap $5.50MP/E –Yield –

Soligenix revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Soligenix's revenue for the twelve months ending Dec 31, 2024 was $119.37K, down 85.8% year over year. For fiscal 2024 it was $119.37K, down 85.8% from the year before. Over ten years it grew -33.5% a year on average. The highest annual figure on record is $10.45M in fiscal 2016.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$119.37K-85.8%
FY2023Dec 31, 2023$839.36K-11.5%
FY2022Dec 31, 2022$948.91K+15.1%
FY2021Dec 31, 2021$824.27K-65.1%
FY2020Dec 31, 2020$2.36M-49.0%
FY2019Dec 31, 2019$4.63M-11.7%
FY2018Dec 31, 2018$5.24M-3.5%
FY2017Dec 31, 2017$5.43M-48.0%
FY2016Dec 31, 2016$10.45M+19.2%
FY2015Dec 31, 2015$8.77M+24.5%
FY2014Dec 31, 2014$7.04M+118.4%
FY2013Dec 31, 2013$3.22M+2.5%
FY2012Dec 31, 2012$3.14M-59.0%
FY2011Dec 31, 2011$7.66M+293.4%
FY2010Dec 31, 2010$1.95M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$2.34K-98.9%
Q1 FY2024Mar 31, 2024$117.03K-54.5%
Q4 FY2023Dec 31, 2023$244.81K-33.1%
Q3 FY2023Sep 30, 2023$130.44K-21.5%
Q2 FY2023Jun 30, 2023$206.93K-9.5%
Q1 FY2023Mar 31, 2023$257.18K+36.8%
Q4 FY2022Dec 31, 2022$366.07K+32.8%
Q3 FY2022Sep 30, 2022$166.14K-10.8%
Q2 FY2022Jun 30, 2022$228.64K+6.4%
Q1 FY2022Mar 31, 2022$188.06K+27.4%
Q4 FY2021Dec 31, 2021$275.65K-14.1%
Q3 FY2021Sep 30, 2021$186.20K-69.4%
Q2 FY2021Jun 30, 2021$214.82K-57.5%
Q1 FY2021Mar 31, 2021$147.59K-84.0%
Q4 FY2020Dec 31, 2020$320.79K-72.0%
Q3 FY2020Sep 30, 2020$608.81K-40.0%
Q2 FY2020Jun 30, 2020$505.29K-63.4%
Q1 FY2020Mar 31, 2020$924.55K-46.4%
Q1 FY2019Mar 31, 2019$1.14M+2.2%
Q4 FY2018Dec 31, 2018$1.01M-21.2%
Q3 FY2018Sep 30, 2018$1.38M-24.2%
Q2 FY2018Jun 30, 2018$1.73M+74.1%
Q1 FY2018Mar 31, 2018$1.12M-15.9%
Q4 FY2017Dec 31, 2017$1.29M-24.1%
Q3 FY2017Sep 30, 2017$1.82M-38.4%
Q2 FY2017Jun 30, 2017$990.97K-68.6%
Q1 FY2017Mar 31, 2017$1.33M-49.4%
Q4 FY2016Dec 31, 2016$1.70M–
Q3 FY2016Sep 30, 2016$2.96M–
Q2 FY2016Jun 30, 2016$3.16M–
Q1 FY2016Mar 31, 2016$2.63M–

More Soligenix figures

See a number that looks wrong?